Logos Capital
San Francisco, Californialogoscapital.com
Overview
Logos Capital is a venture capital firm founded in 2019 that is dedicated to advancing healthcare through disciplined, data-driven investments in biotechnology. The firm, led by founder Dr. Arsani William, combines scientific and financial expertise to identify and fund life-changing therapeutics that generate superior long-term returns for investors. It utilizes a proprietary data science platform, Logos Analytics, to enhance decision-making by predicting clinical trial outcomes. The firm invests in both private and public companies.
Portfolio Companies
65
Website
logoscapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Serapha Bio | Jun 2026 | Series A | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
| Adcendo | Apr 2026 | Series C | Co-investor |
| Beacon Biosignals | Apr 2026 | Series B Extension | Co-investor |
| Pinnacle Medicines | Mar 2026 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
